Why Claritev Corporation’s (CTEV) Stock Is Up 5.68%
As of Tuesday, July 28, Claritev Corporation’s CTEV share price has surged by 5.68%, which has investors questioning if this is right time to sell.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Commentary & Analysis
Why Claritev Corporation’s (CTEV) Stock Is Down 7.83%
As of Thursday, July 23, Claritev Corporation’s CTEV share price has dipped by 7.83%, which has investors questioning if this is right time to buy.Michael Rose
Why Claritev Corporation’s (CTEV) Stock Is Down 10.91%
As of Wednesday, July 22, Claritev Corporation’s CTEV share price has dipped by 10.91%, which has investors questioning if this is right time to buy.Omar Beirat
Why Claritev Corporation’s (CTEV) Stock Is Down 6.50%
As of Wednesday, July 22, Claritev Corporation’s CTEV share price has dipped by 6.50%, which has investors questioning if this is right time to buy.Rosalio Madrigal
3 Undervalued Health Care Technology Stocks for Monday, July 20
Discover the top 3 undervalued Health Care Technology stocks for Monday, July 20 based on AAII’s Stock Grades.Rosalio Madrigal
Financial Summary
| Share Statistics | CTEV | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $387.2 | $179.6 | 35% |
|
| Shares Out (Mil) | 16.7 | 47.9 | 28% |
|
| Institutional Ownership | 78.6% | 78.6% | 48% |
|
| Float (Mil) | 5.8 | 40.1 | 13% |
|
| Beta | 0.77 | 1.22 | 45% |
|
| Avg Daily Volume (000s) | 100 | 205 | 36% |
|
| Price Change (52-week) |
(41.3%) | 41.0% | 19% |
|
| Growth | CTEV | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 0.6% | 13.7% | 19% |
|
| Net Income (5yr) | 11.4% | (1.0%) | 57% |
|
| EPS (5yr) | 17.2% | 15.5% | 62 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (15.0%) | (15.5%) | 52% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | 1 | 1 | |
| Current EPS | $1.330 | $5.580 | $6.840 | |
| Month Ago EPS | $1.330 | $5.580 | $6.840 | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | $1.430 | $5.490 | $6.840 | |
| Year/Year Chg | (130.2%) | (132.3%) | (144.6%) | |
| Financials | CTEV | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $979 | $192 | 50% |
|
| Net Income (TTM) (Mil) | ($287) | ($9) | 5% |
|
| EPS (TTM) | ($17.323) | ($0.500) | 3% |
|
| Operating Cash Flow (TTM) (Mil) | $102 | $8 | 53% |
|
| Net Cash Flow (TTM) (Mil) | $1 | ($3) | 46% |
|
| Long-Term Debt (Q1) (Mil) | $4,714 | $14 | 85% |
|
| Enterprise Value (Q1) (Mil) | $5,183 | $215 | 63% |
|
| Valuation | CTEV | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.22 | na |
|
| P/E | na | 36.1 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.0 | na |
|
| Ratios | CTEV | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 73.2% | 61.6% | 84% |
|
| Net Margin | (29.3%) | (29.3%) | 15% |
|
| ROA | (5.8%) | (21.9%) | 29% |
|
| ROE | 253.2% | (1.4%) | 98% |
|
| Liabilities to Assets | 104.8% | 33.3% | 95% |
|
| F-Score | 5 | 4 | 51% |
|
Claritev Corporation did not pass any screens on 7/31/2026.
